Diagnosis and management of neuropathic pain
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
#### Summary points Neuropathic pain arises from damage, or pathological change, in the peripheral or central nervous system. It is usually a chronic condition that can be difficult to treat because standard treatment with conventional analgesics does not typically provide effective relief of pain. Patients with neuropathic pain commonly present to primary care professionals, but making a diagnosis may be difficult. Neuropathic pain is usually associated with substantially greater impairment of quality of life compared with other types of chronic pain, and the disorder is a large cost burden on healthcare services. In this review, we provide an overview of published evidence to help clinicians recognise and manage patients with neuropathic pain. A group of specialists of the International Association for the Study of Pain defines neuropathic pain as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system.”1 In contrast to inflammatory or nociceptive pain, which is caused by actual tissue damage or potentially tissue damaging stimuli, neuropathic pain is produced either by damage to, or pathological change in, the peripheral or central nervous system, the system that normally signals pain. As such, the term neuropathic pain represents a varying set of symptoms rather than a single diagnosis. Damage to the somatosensory system can provoke a range of responses; an absence of sensation and pain is probably a more common response than new onset of …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freynhagen, R., Baron, R., Gockel, U., & Tölle, T. R. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132488 · Cited by 2,280
Self-citationPharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126 · cited 1×
“Unfortunately, there is no absolute consistency from the four most recently published guidelines and algorithms regarding the assessment of first, second, and third line drug treatments for neuropathic pain, although consistency exists for the classes of medication.”
BackgroundAAN-EFNS guidelines on trigeminal neuralgia management
Cruccu, G., Gronseth, G., Alksne, J., Argoff, C., Brainin, M., Burchiel, K., Nurmikko, T., & Zakrzewska, J. M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02185.x · Cited by 726
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Iskedjian, M., Bereza, B., Gordon, A., Piwko, C., & Einarson, T. R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x158066 · Cited by 216 · cited 1×
“There are encouraging results from studies regarding cannabinoids, but their future role in the treatment of neuropathic pain has still to be determined.”
ResultBennett, M. I., Smith, B. H., Torrance, N., & Lee, A. J. (2006) · Pain · doi:10.1016/j.pain.2006.02.002 · Cited by 169
Self-citation
Cited by
Tesfaye, S., Vileikyte, L., Rayman, G., Sindrup, S. H., Perkins, B. A., Baconja, M., Vinik, A. I., Boulton, A. J. M., & Neuropathy, O. B. O. T. T. E. P. O. D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1225 · Cited by 410
Tesfaye, S., Wilhelm, S., Lledo, A., Schacht, A., Tölle, T., Bouhassira, D., Cruccu, G., Skljarevski, V., & Freynhagen, R. (2013) · Pain · doi:10.1016/j.pain.2013.05.043 · Cited by 311
Self-citationBaron, R., Freynhagen, R., Tölle, T. R., Cloutier, C., Leon, T., Murphy, K. T., & Phillips, K. (2010) · Pain · doi:10.1016/j.pain.2010.04.013 · Cited by 163
Self-citationSadosky, A., Parsons, B., Schaefer, C., Mann, R., Daniel, S., Nalamachu, S., Stacey, B. R., Nieshoff, E., Tuchman, M., & Anschel, A. (2013) · Journal of Pain Research · doi:10.2147/jpr.s44939 · Cited by 137
Parsons, B., & Li, C. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1151776 · Cited by 20
Metadata
- Authors
- Freynhagen, R., & Bennett, M. I.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2009-08-12
- Volume
- 339
- Issue
- aug12 1
- Pages
- b3002-b3002
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2065199904
- Cited by
- 193
- References
- 5
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.